Press Releases
-
GenNext Technologies Appoints Dr. Lisa Jones of UCSD to the Role of Chief Science Officer (CSO)
GenNext Technologies, Inc. adds to the strength of their leadership team with the selection of Dr. Lisa Jones as the company’s new CSO.
Jan 18, 2023
-
New Hope in Combatting MRSA Superbug in Hospital Infections
Seven-month study in an urban medical-surgical ICU highlights the impact of ActivePures proactive, continuous, disinfection technology on HAIs. Healthcare-Onset MRSA (HO-MRSA) bacteremia infections had a statistically significant 100% decrease (and in fact were eliminated during the trial period) when compared to the same time frame a year prior and the immediate six months prior.
Jan 16, 2023
-
Biopharma PEG Provides PEG Products Used As ADC Linker
About Biopharma PEG As a leading manufacturer of PEG derivatives, Biochempeg is dedicated to being your most reliable partner to provide a chemical synthesis and high-quality PEG linkers. We are committed to promoting the progress of your ADC discovery and development projects. Contact us Biopharma PEG Scientific Inc. Address: 108 Water Street, Room 4D, Watertown, MA 02472, USA TEL: 1-857-366-6766 Fax: 617-206-9595 Email: sales@biochempeg.com Website:https://www.biochempeg.com/
Jan 16, 2023
-
Three Ion Exchange Resins Released: Mixed Bed Resins, Chelating Resins, and Adsorbent Resins
-
Integrated Development Services for Health Care Products
-
Why Are Carbon Nanomaterials Favored by Researchers?
-
CD Formulation Offers 16 types of Food Ingredients as Raw Materials to Manufacture Health Care Products
-
Drug Discovery: Combining the Power of Computational Chemistry with Multiple Applications
-
Alfa Chemistry Now Becomes A High-Quality 2D Material Supplier
-
Tower expands pharmaceutical corridors with new Singapore site
Pharmaceutical thermal protection specialist Tower Cold Chain is opening new office space in Tampines, Singapore, to support the company’s growth in the Asia Pacific region.
Jan 12, 2023
-
Samsung Biologics receives the Terra Carta Seal in recognition of the company’s commitment to creating a sustainable future
-
Isohelix Files US FDA 510k Pre-Submission for GeneFix® Saliva DNA Collectors
Isohelix has announced that it has commenced engagement with the U.S. Food and Drug Administration to progress the full regulatory approval of the GeneFix® Saliva DNA Collectors into the USA.
Jan 10, 2023
-
GenNext Technologies Appoints Dr. Lisa Jones of UCSD to the Role of Chief Science Officer (CSO)
GenNext Technologies has announced the appointment of Dr. Lisa Jones as the company’s new Chief Science Officer.
Jan 10, 2023
-
GenNext Technologies Announces the Appointment of Dr. John Grant from Lemnos Advisory to its Board of Directors
GenNext Technologies, Inc. has announced that Dr. John L. Grant has joined its Board of Directors (BOD).
Jan 10, 2023
-
Argonaut Manufacturing Services Set to Expand Drug Product Fill/Finish Capabilities with Significant Capital Investment
Argonaut Manufacturing Services Set to Expand Drug Product Fill/Finish Capabilities with Significant Capital Investment
Jan 9, 2023
-
Phastar enhances Data Visualization and Analytics solution through acquisition of S-Cubed ApS, adds capability in Denmark
Phastar enhances Data Visualization and Analytics solution through acquisition of S-Cubed ApS, adds capability in Denmark. London, UK and Durham, NC – January 10, 2023 – Phastar announced today the acquisition of S-Cubed ApS, a specialist biometrics and data visualization company. The deal takes the PHASTAR group to around 550 people worldwide and strengthens the company's position in the Nordic region.
Jan 9, 2023
-
SANGUINE BIOSCIENCES PARTNERS WITH BROADOAK CAPITAL PARTNERS TO ACCELERATE LAUNCH OF NEW PRODUCTS AND SERVICES IN SUPPORT OF CELL & GENE THERAPY MARKETS
Investment will support ongoing partnerships with apheresis clinics, expansion of laboratory services, enhancement of patient data aggregation, and amplification of Sanguine’s network of 60,000+ research-ready patient donor network.
Jan 8, 2023
-
Quanticate makes key appointment to bolster leadership team
-
Battelle, AmplifyBio, Andelyn Biosciences Win Research Contract for National Institute of Neurological Disorders and Stroke
Battelle, AmplifyBio, Andelyn Biosciences Win Research Contract for National Institute of Neurological Disorders and Stroke
Jan 5, 2023
-
Elligo Health Research® Names Dawn Sauro as New Chief Operating Officer